-
2
-
-
0021272605
-
Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation
-
Anderson KC, Bates MP, Slaughenhoupt BL, Pinkus GS, Schlossman SF, Nadler LM: Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation. Blood 63:1424, 1984
-
(1984)
Blood
, vol.63
, pp. 1424
-
-
Anderson, K.C.1
Bates, M.P.2
Slaughenhoupt, B.L.3
Pinkus, G.S.4
Schlossman, S.F.5
Nadler, L.M.6
-
3
-
-
0020031557
-
Treatment of B cell lymphoma with monoclonal anti-idiotype antibody
-
Miller RA, Maloney DG, Warnke R, Levy R: Treatment of B cell lymphoma with monoclonal anti-idiotype antibody. N EngI J Med 306:517, 1982
-
(1982)
N EngI J Med
, vol.306
, pp. 517
-
-
Miller, R.A.1
Maloney, D.G.2
Warnke, R.3
Levy, R.4
-
4
-
-
0024502001
-
Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon
-
Brown SL, Miller RA, Horning SJ, Czerwinski D, Hart SM, McElderry R, Basham T, Warnke RA, Merigan TC, Levy R: Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 73:651, 1989
-
(1989)
Blood
, vol.73
, pp. 651
-
-
Brown, S.L.1
Miller, R.A.2
Horning, S.J.3
Czerwinski, D.4
Hart, S.M.5
McElderry, R.6
Basham, T.7
Warnke, R.A.8
Merigan, T.C.9
Levy, R.10
-
5
-
-
0024389456
-
Antiidiotype antibody therapy of B-cell lymphoma
-
Brown S, Miller R, Levy R: Antiidiotype antibody therapy of B-cell lymphoma. Semin Oncol 16:199, 1989
-
(1989)
Semin Oncol
, vol.16
, pp. 199
-
-
Brown, S.1
Miller, R.2
Levy, R.3
-
6
-
-
0026668842
-
Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: The addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype negative variant cells
-
Maloney D, Brown S, Czerwinski D, Liles TM, Man S, Miller R, Levy R: Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: The addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype negative variant cells. Blood 80:1502, 1992
-
(1992)
Blood
, vol.80
, pp. 1502
-
-
Maloney, D.1
Brown, S.2
Czerwinski, D.3
Liles, T.M.4
Man, S.5
Miller, R.6
Levy, R.7
-
7
-
-
0021795011
-
A clinical trial of anti-idiotype therapy for B cell malignancy
-
Meeker TC, Lowder J, Maloney DG, Miller RA, Thielemans K, Wamke R, Levy R: A clinical trial of anti-idiotype therapy for B cell malignancy. Blood 65:1349, 1985
-
(1985)
Blood
, vol.65
, pp. 1349
-
-
Meeker, T.C.1
Lowder, J.2
Maloney, D.G.3
Miller, R.A.4
Thielemans, K.5
Wamke, R.6
Levy, R.7
-
8
-
-
0019521216
-
The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma
-
Hatzubai A, Maloney D, Levy R: The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma. J Immunol 126:2397, 1981
-
(1981)
J Immunol
, vol.126
, pp. 2397
-
-
Hatzubai, A.1
Maloney, D.2
Levy, R.3
-
9
-
-
0024414981
-
Shared idiotypes expressed by human B-cell lymphomas
-
Miller RA, Hart S, Samoszuk M, Coulter C, Brown S, Czerwinski D, Kelkenberg J, Royston I, Levy R: Shared idiotypes expressed by human B-cell lymphomas. N Engl J Med 321:851, 1989
-
(1989)
N Engl J Med
, vol.321
, pp. 851
-
-
Miller, R.A.1
Hart, S.2
Samoszuk, M.3
Coulter, C.4
Brown, S.5
Czerwinski, D.6
Kelkenberg, J.7
Royston, I.8
Levy, R.9
-
10
-
-
0021792139
-
Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies
-
Meeker T, Lowder J, Cleary ML, Stewart S, Warnke R, Sklar J, Levy R: Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N Engl J Med 312:1658, 1985
-
(1985)
N Engl J Med
, vol.312
, pp. 1658
-
-
Meeker, T.1
Lowder, J.2
Cleary, M.L.3
Stewart, S.4
Warnke, R.5
Sklar, J.6
Levy, R.7
-
11
-
-
0026353797
-
All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment
-
Gribben JG, Freedman A, Woo SD, Blake K, Shu RS, Freeman G, Longtine JA, Pinkus GS, Nadler LM: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275, 1991
-
(1991)
Blood
, vol.78
, pp. 3275
-
-
Gribben, J.G.1
Freedman, A.2
Woo, S.D.3
Blake, K.4
Shu, R.S.5
Freeman, G.6
Longtine, J.A.7
Pinkus, G.S.8
Nadler, L.M.9
-
12
-
-
0023798586
-
Detection of occult follicular lymphoma by specific DNA amplification
-
Stetlet-Stevenson M, Raffeld M, Cohen P, Cossman J: Detection of occult follicular lymphoma by specific DNA amplification. Blood 72:1822, 1988
-
(1988)
Blood
, vol.72
, pp. 1822
-
-
Stetlet-Stevenson, M.1
Raffeld, M.2
Cohen, P.3
Cossman, J.4
-
13
-
-
0011063097
-
Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using CDR3 specific probes
-
Yamada M, Hudson S, Tournay O, Bittenbender S, Shane S, Lange B, Tsujimoto Y, Caton A, Rovera G: Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using CDR3 specific probes. Proc Natl Acad Sci USA 86:5123, 1989
-
(1989)
Proc Natl Acad Sci USA
, vol.86
, pp. 5123
-
-
Yamada, M.1
Hudson, S.2
Tournay, O.3
Bittenbender, S.4
Shane, S.5
Lange, B.6
Tsujimoto, Y.7
Caton, A.8
Rovera, G.9
-
14
-
-
0027232355
-
PCR-based immunogenotyping at the Ig heavy chain CDR3 locus: Improvements in resolution
-
Pollard P, Owen G, Worwood M: PCR-based immunogenotyping at the Ig heavy chain CDR3 locus: Improvements in resolution. Br J Haematol 84:169, 1993
-
(1993)
Br J Haematol
, vol.84
, pp. 169
-
-
Pollard, P.1
Owen, G.2
Worwood, M.3
-
15
-
-
0029005511
-
Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias
-
Linke B, Pyttlich J, Tiemann M, Suttorp M, Parwaresch R, Hiddemann W, Kneba M: Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias. Leukemia 9:840, 1995
-
(1995)
Leukemia
, vol.9
, pp. 840
-
-
Linke, B.1
Pyttlich, J.2
Tiemann, M.3
Suttorp, M.4
Parwaresch, R.5
Hiddemann, W.6
Kneba, M.7
-
16
-
-
0027235630
-
Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma
-
Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N, Rabinowe SN, Grossbard ML, Ritz J, Nadler LM: Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81:3449, 1993
-
(1993)
Blood
, vol.81
, pp. 3449
-
-
Gribben, J.G.1
Neuberg, D.2
Freedman, A.S.3
Gimmi, C.D.4
Pesek, K.W.5
Barber, M.6
Saporito, L.7
Woo, S.D.8
Coral, F.9
Spector, N.10
Rabinowe, S.N.11
Grossbard, M.L.12
Ritz, J.13
Nadler, L.M.14
-
17
-
-
0028284263
-
Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow
-
Gribben JG, Neuberg D, Barber M, Moore J, Pesek KW, Freedman AS, Nadler LM: Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994
-
(1994)
Blood
, vol.83
, pp. 3800
-
-
Gribben, J.G.1
Neuberg, D.2
Barber, M.3
Moore, J.4
Pesek, K.W.5
Freedman, A.S.6
Nadler, L.M.7
-
18
-
-
0026545710
-
Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: Implications for the design of oligo-nucleotide probes for use in monitoring minimal residual disease
-
Steward CG, Potter MN, Oakhill A: Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: Implications for the design of oligo-nucleotide probes for use in monitoring minimal residual disease. Leukemia 6:1213, 1992
-
(1992)
Leukemia
, vol.6
, pp. 1213
-
-
Steward, C.G.1
Potter, M.N.2
Oakhill, A.3
-
19
-
-
0028127935
-
Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of bcl-2 protein
-
Vuist WM, Levy R, Maloney DG: Lymphoma regression induced by monoclonal anti-idiotypic antibodies correlates with their ability to induce Ig signal transduction and is not prevented by tumor expression of high levels of bcl-2 protein. Blood 83:899, 1994
-
(1994)
Blood
, vol.83
, pp. 899
-
-
Vuist, W.M.1
Levy, R.2
Maloney, D.G.3
-
20
-
-
0026558821
-
Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death
-
Ishigami T, Kim KM, Horiguchi Y, Higaki Y, Hata D, Heike T, Katamura K, Mayumi M, Mikawa H: Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death. J Immunol 148:360, 1992
-
(1992)
J Immunol
, vol.148
, pp. 360
-
-
Ishigami, T.1
Kim, K.M.2
Horiguchi, Y.3
Higaki, Y.4
Hata, D.5
Heike, T.6
Katamura, K.7
Mayumi, M.8
Mikawa, H.9
-
21
-
-
0025276998
-
Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells
-
Benhamou LE, Cazenave PA, Sarthou P: Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol 20:1405, 1990
-
(1990)
Eur J Immunol
, vol.20
, pp. 1405
-
-
Benhamou, L.E.1
Cazenave, P.A.2
Sarthou, P.3
-
22
-
-
0025788312
-
The role of tyrosine protein phosphorylation in lymphocyte activation
-
Sefton BM, Campbell MA: The role of tyrosine protein phosphorylation in lymphocyte activation. Annu Rev Cell Biol 7:257, 1991
-
(1991)
Annu Rev Cell Biol
, vol.7
, pp. 257
-
-
Sefton, B.M.1
Campbell, M.A.2
-
23
-
-
0025126816
-
Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas
-
Hasbold J, Klaus GG: Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur J Immunol 20:1685, 1990
-
(1990)
Eur J Immunol
, vol.20
, pp. 1685
-
-
Hasbold, J.1
Klaus, G.G.2
-
24
-
-
0028333754
-
Synthetic peptide ligands of the antigen binding receptor induce programmed cell death in a human B-cell lymphoma
-
Renschler MF, Bhatt RR, Dower WJ, Levy R: Synthetic peptide ligands of the antigen binding receptor induce programmed cell death in a human B-cell lymphoma. Proc Natl Acad Sci USA 91:3623, 1994
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 3623
-
-
Renschler, M.F.1
Bhatt, R.R.2
Dower, W.J.3
Levy, R.4
-
25
-
-
0030915612
-
Cancer dormancy: Opportunities for new therapeutic approaches
-
Uhr JW, Scheuermann RH, Street NE, Vitetta ES: Cancer dormancy: Opportunities for new therapeutic approaches. Nat Med 3:505, 1997
-
(1997)
Nat Med
, vol.3
, pp. 505
-
-
Uhr, J.W.1
Scheuermann, R.H.2
Street, N.E.3
Vitetta, E.S.4
-
26
-
-
0029859082
-
Role of antibody signaling in inducing tumor dormancy
-
Uhr JW, Marches R, Racila E, Tucker TF, Hsueh R, Street NE, Vitetta ES, Scheuermann RH: Role of antibody signaling in inducing tumor dormancy. Adv Exp Med Biol 406:69, 1996
-
(1996)
Adv Exp Med Biol
, vol.406
, pp. 69
-
-
Uhr, J.W.1
Marches, R.2
Racila, E.3
Tucker, T.F.4
Hsueh, R.5
Street, N.E.6
Vitetta, E.S.7
Scheuermann, R.H.8
-
27
-
-
0028968004
-
Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice
-
Racila E, Scheuennann R, Picker L, Yefenof E, Tucker T, Chang W, Marches R, Street N, Vitetta E, Uhr J: Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice. J Exp Med 181:1539, 1995
-
(1995)
J Exp Med
, vol.181
, pp. 1539
-
-
Racila, E.1
Scheuennann, R.2
Picker, L.3
Yefenof, E.4
Tucker, T.5
Chang, W.6
Marches, R.7
Street, N.8
Vitetta, E.9
Uhr, J.10
-
28
-
-
0027462883
-
Cancer Dormancy: Isolation and characterization of dormant lymphoma cells
-
Yefenof E, Picker L, Scheuermann R, Tucker T, Vitteta E, Uhr J: Cancer Dormancy: Isolation and characterization of dormant lymphoma cells. Proc Natl Acad Sci USA 90:1829, 1992
-
(1992)
Proc Natl Acad Sci USA
, vol.90
, pp. 1829
-
-
Yefenof, E.1
Picker, L.2
Scheuermann, R.3
Tucker, T.4
Vitteta, E.5
Uhr, J.6
-
29
-
-
0030912221
-
Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established
-
Vitteta E, Tucker T, Racila E, Huang Y, Marches R, Lane N, Scheuermann R, Street N, Watanabe T, Uhr J: Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established. Blood 89:4425, 1997
-
(1997)
Blood
, vol.89
, pp. 4425
-
-
Vitteta, E.1
Tucker, T.2
Racila, E.3
Huang, Y.4
Marches, R.5
Lane, N.6
Scheuermann, R.7
Street, N.8
Watanabe, T.9
Uhr, J.10
-
30
-
-
0029548298
-
Tumour dormancy and cell signalling - III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells
-
Marches R, Racila E, Tucker TF, Picker L, Mongini P, Hsueh R, Vitetta ES, Scheuermann RH, Uhr JW: Tumour dormancy and cell signalling - III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells. Ther Immunol 2:125, 1995
-
(1995)
Ther Immunol
, vol.2
, pp. 125
-
-
Marches, R.1
Racila, E.2
Tucker, T.F.3
Picker, L.4
Mongini, P.5
Hsueh, R.6
Vitetta, E.S.7
Scheuermann, R.H.8
Uhr, J.W.9
-
31
-
-
0027074260
-
Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage ALL
-
Wasserman R, Galili N, Ito Y, Silber J, Reichard B, Shane S, Womer R, Lange B, Rovera G: Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage ALL. J Clin Oncol 10:1879, 1992
-
(1992)
J Clin Oncol
, vol.10
, pp. 1879
-
-
Wasserman, R.1
Galili, N.2
Ito, Y.3
Silber, J.4
Reichard, B.5
Shane, S.6
Womer, R.7
Lange, B.8
Rovera, G.9
-
32
-
-
0028079571
-
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: High remission rates and reversion to negative of peripheral blood bcl-2 rearrangement
-
McLaughlin P, Hagemeister FB, Swan F, Cabanillas F, Romaguera J, Rodriguez MA, Lee MS, Pate O, Sarris A, Younes A: Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: High remission rates and reversion to negative of peripheral blood bcl-2 rearrangement. Ann Oncol 5:73, 1994 (suppl 2)
-
(1994)
Ann Oncol
, vol.5
, Issue.SUPPL. 2
, pp. 73
-
-
McLaughlin, P.1
Hagemeister, F.B.2
Swan, F.3
Cabanillas, F.4
Romaguera, J.5
Rodriguez, M.A.6
Lee, M.S.7
Pate, O.8
Sarris, A.9
Younes, A.10
-
33
-
-
0027293902
-
Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma
-
Finke J, Slanina J, Lange W, Dolken G: Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol 11:1668, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 1668
-
-
Finke, J.1
Slanina, J.2
Lange, W.3
Dolken, G.4
-
34
-
-
0031016326
-
Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia
-
Roberts W, Estrov Z. Ouspenskaia M, Johnston D, McClain K, Zipf T: Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. N Engl J Med 336:317, 1997
-
(1997)
N Engl J Med
, vol.336
, pp. 317
-
-
Roberts, W.1
Ouspenskaia M, E.Z.2
Johnston, D.3
McClain, K.4
Zipf, T.5
-
35
-
-
0031018034
-
Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: A preliminary report
-
Ha C, Cabanillas F, Lee M, Besa P, McLaughlin P, Cox J: Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: A preliminary report. Clin Cancer Res 3:215, 1997
-
(1997)
Clin Cancer Res
, vol.3
, pp. 215
-
-
Ha, C.1
Cabanillas, F.2
Lee, M.3
Besa, P.4
McLaughlin, P.5
Cox, J.6
-
36
-
-
0026357520
-
Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia
-
Limpens J, de long D, van Krieken JH, Price CG, Young BD, van Ommen GJ, Kluin PM: Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271, 1991
-
(1991)
Oncogene
, vol.6
, pp. 2271
-
-
Limpens, J.1
De Long, D.2
Van Krieken, J.H.3
Price, C.G.4
Young, B.D.5
Van Ommen, G.J.6
Kluin, P.M.7
-
37
-
-
0028914585
-
Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals
-
Limpens J, Stad R, Vos C, de Vlaam C, de long D, van Ommen GJ, Schuuring E, Kluin PM: Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85:2528, 1995
-
(1995)
Blood
, vol.85
, pp. 2528
-
-
Limpens, J.1
Stad, R.2
Vos, C.3
De Vlaam, C.4
De Long, D.5
Van Ommen, G.J.6
Schuuring, E.7
Kluin, P.M.8
-
38
-
-
0029665393
-
BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases
-
Dolken G, Illerhaus G, Hirt C, Mertelsmann R: BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 14:1333, 1996
-
(1996)
J Clin Oncol
, vol.14
, pp. 1333
-
-
Dolken, G.1
Illerhaus, G.2
Hirt, C.3
Mertelsmann, R.4
-
39
-
-
0023161404
-
Somatic mutation in human B cell tumors
-
Levy R, Levy S, Cleary M, Carroll W, Kon S, Bird J, Sklar J: Somatic mutation in human B cell tumors. Immunol Rev 96:43, 1987
-
(1987)
Immunol Rev
, vol.96
, pp. 43
-
-
Levy, R.1
Levy, S.2
Cleary, M.3
Carroll, W.4
Kon, S.5
Bird, J.6
Sklar, J.7
-
40
-
-
0026793994
-
Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors
-
Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R: Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 327:1209, 1992
-
(1992)
N Engl J Med
, vol.327
, pp. 1209
-
-
Kwak, L.W.1
Campbell, M.J.2
Czerwinski, D.K.3
Hart, S.4
Miller, R.A.5
Levy, R.6
-
41
-
-
0031007771
-
Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - Long-term results of a clinical trial
-
Hsu FJ, Caspar CB, Czerwinski D, Kwak LW, Liles TM, Syrengelas A, Taidi-Laskowski B, Levy R: Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - long-term results of a clinical trial. Blood 89:3129, 1997
-
(1997)
Blood
, vol.89
, pp. 3129
-
-
Hsu, F.J.1
Caspar, C.B.2
Czerwinski, D.3
Kwak, L.W.4
Liles, T.M.5
Syrengelas, A.6
Taidi-Laskowski, B.7
Levy, R.8
-
42
-
-
0030026776
-
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
-
Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2:52, 1996
-
(1996)
Nat Med
, vol.2
, pp. 52
-
-
Hsu, F.J.1
Benike, C.2
Fagnoni, F.3
Liles, T.M.4
Czerwinski, D.5
Taidi, B.6
Engleman, E.G.7
Levy, R.8
|